Which zinc form is best: picolinate, citrate, or glycinate?

How it works

Picolinic acid (in picolinate), glycine (in bisglycinate), and L-carnosine each provide a chelating ligand. The historical Barrie 1987 picolinate-superiority finding is small (n=15) and has not been consistently replicated; modern evidence shows similar absorption among picolinate, citrate, and bisglycinate. Lozenges deliver zinc directly to oropharyngeal mucosa where local action on rhinovirus replication may explain the cold-duration effect (Hemilä 2017 BMJ Open). Zinc carnosine delivers zinc to gastric mucosa where it has been studied for gastric mucosal protection (Mahmood 2007 Gut 56(2):168-175).

Effective dose

Above 25 mg/day chronic risks copper deficiency, immune effects, and possible CV effects (UK SACN). The US 40 mg/day UL (NIH ODS) is less strict; UK/EU at 25 mg/day is the more conservative anchor. Most UK prenatal multivitamins provide 10-15 mg zinc which is adequate. Therapeutic supplemental zinc above RNI not adequately studied in pregnancy beyond moderate doses.

Forms compared

Lozenge use: zinc acetate or zinc gluconate lozenges providing more than 75 mg elemental zinc/day reduce common cold duration around 33% when started within 24 hours of symptom onset (Hemilä 2017 BMJ Open 7(1):e013657). Side effects: oral irritation, taste alteration, nausea common at therapeutic lozenge doses. Use is for cold-duration shortening only, not for cold prophylaxis. Zinc sulphate is the cheapest oral form (used in some prescription products like Solvazinc effervescent tablets per UK BNF) but tolerability is poor.

Timing

Onset of clinical copper deficiency from chronic high-dose zinc loading: typically months to years (see zinc-copper interaction entry 206a1d13). Cold lozenge effect onset: within 24 hours of starting if started early in symptom course; later starts show diminishing benefit. The 24-hour symptom-onset window is the central practical timing constraint for the lozenge application.

Safety profile

Long-term excess zinc can cause copper deficiency: microcytic anaemia, neutropaenia, neurological symptoms (myelopathy), severe cases neuropathy. If long-term zinc supplementation above 15 mg/day is clinically necessary: add copper 1-2 mg per 15 mg zinc above maintenance per Prasad 2020. The Brewer 1998 protocol of zinc 50 mg three times daily for Wilson disease is a recognised specialist context, not generalisable to non-Wilson populations.

Special populations

Older adults: higher prevalence of dietary zinc inadequacy plus longer duration of supplement exposure increases copper-depletion risk; balance any chronic high-dose zinc with copper. Wilson disease (Brewer 1998): zinc 50 mg three times daily is a specialist-managed approach, not generalisable. Older adults with denture adhesives: documented exogenous zinc source; combined with supplements can produce inadvertent high-dose exposure.

Interactions

(6) Bisphosphonates: modest interference; separate per medication-specific guidance. (7) Thiazide diuretics: increase zinc excretion; modestly increased zinc requirement. (8) Copper: zinc loading reduces copper absorption via metallothionein induction; chronic high-dose zinc requires copper supplementation 1-2 mg per 15 mg zinc above maintenance. (9) ACE inhibitors and ARBs: some literature suggests zinc loss; clinical significance debated.

Guideline positions

Hemilä 2017 meta-analysis: zinc acetate or zinc gluconate lozenges providing more than 75 mg elemental zinc/day reduced common cold duration around 33% when started within 24 hours of symptom onset; not effective for cold prophylaxis. Barrie 1987 small comparative study (n=15) showed picolinate superior to citrate or gluconate for serum zinc; subsequent evidence less consistent and modern evidence shows similar absorption among picolinate, citrate, and bisglycinate. Prasad 2020 review covers the copper-balance protocol. Brewer 1998 covers Wilson disease zinc protocol. Hewlings 2020 reviews zinc carnosine evidence.

Practical framework

Chronic zinc above 15 mg/day requires copper 1-2 mg per 15 mg zinc to balance; chronic above 25 mg/day requires monitoring per UK SACN UL. Wilson disease zinc 50 mg three times daily is specialist context. Drug interactions: quinolones and tetracyclines 2-4 hours separation; iron and calcium 2 hours; penicillamine specialist context; bisphosphonates per medication-specific guidance; thiazide diuretics increase zinc requirement modestly. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: zinc lozenges are useful for cold prophylaxis. Hemilä 2017 evidence is for cold-duration shortening when started within 24 hours of symptom onset, not for cold prophylaxis. Daily lozenges as a routine prophylactic measure are not supported.

Claim: chronic high-dose zinc is safe at the US 40 mg/day UL. The UK SACN and EFSA UL is 25 mg/day, the more conservative anchor; chronic above 25 mg/day risks copper deficiency, immune effects, and possible cardiovascular effects.